Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Tamoxifen
Vorinostat
+1 more
Locations
15
United States
Alabama CRS
Birmingham, Alabama, United States
UCLA CARE Center CRS
Los Angeles, California, United States
Ucsf Hiv/Aids Crs
San Francisco, California, United States
Harbor-UCLA CRS
Torrance, California, United States
University of Colorado Hospital CRS
Aurora, Colorado, United States
Whitman-Walker Health CRS
Washington D.C., District of Columbia, United States
Start Date
April 26, 2018
Primary Completion Date
December 4, 2018
Completion Date
July 27, 2023
Last Updated
July 3, 2024
NCT06694805
NCT04142047
NCT05398185
NCT07428330
NCT07225530
NCT06665646
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions